Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Growth 2023-2028

Report ID: 1168767 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country/Region, 2017, 2022 & 2028
    2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
        2.2.1 XIFAXAN
        2.2.2 Viberzi
        2.2.3 Lotronex
        2.2.4 Other
    2.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
        2.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2017-2022)
        2.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Type (2017-2022)
    2.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Sales Channel
        2.4.1 Hospitals Pharmacy
        2.4.2 Retail Pharmacy
        2.4.3 Other
    2.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
        2.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Market Share by Sales Channel (2017-2022)
        2.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Sales Channel (2017-2022)
        2.5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Sales Channel (2017-2022)
3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company
    3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Breakdown Data by Company
        3.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales by Company (2020-2022)
        3.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2020-2022)
    3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue by Company (2020-2022)
        3.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2020-2022)
        3.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2020-2022)
    3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Company
    3.4 Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Location Distribution
        3.4.2 Players Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Geographic Region
    4.1 World Historic Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Geographic Region (2017-2022)
        4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue by Geographic Region
    4.2 World Historic Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country/Region (2017-2022)
        4.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue by Country/Region
    4.3 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
    4.4 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
    4.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
    4.6 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
5 Americas
    5.1 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
        5.1.1 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2022)
        5.1.2 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2017-2022)
    5.2 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
    5.3 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
        6.1.1 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2017-2022)
        6.1.2 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2017-2022)
    6.2 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
    6.3 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
        7.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2022)
        7.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2017-2022)
    7.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
    7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
        8.1.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2017-2022)
    8.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
    8.3 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
    10.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
    10.4 Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors
    11.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customer
12 World Forecast Review for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Geographic Region
    12.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Region
        12.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Region (2023-2028)
        12.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Type
    12.7 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Sales Channel
13 Key Players Analysis
    13.1 Bausch Health
        13.1.1 Bausch Health Company Information
        13.1.2 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
        13.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Bausch Health Main Business Overview
        13.1.5 Bausch Health Latest Developments
    13.2 Allergan
        13.2.1 Allergan Company Information
        13.2.2 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
        13.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Allergan Main Business Overview
        13.2.5 Allergan Latest Developments
    13.3 Sebela Pharmaceuticals
        13.3.1 Sebela Pharmaceuticals Company Information
        13.3.2 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
        13.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Sebela Pharmaceuticals Main Business Overview
        13.3.5 Sebela Pharmaceuticals Latest Developments
    13.4 Astellas Pharmaceuticals
        13.4.1 Astellas Pharmaceuticals Company Information
        13.4.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
        13.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Astellas Pharmaceuticals Main Business Overview
        13.4.5 Astellas Pharmaceuticals Latest Developments
    13.5 Amneal Pharms
        13.5.1 Amneal Pharms Company Information
        13.5.2 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
        13.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Amneal Pharms Main Business Overview
        13.5.5 Amneal Pharms Latest Developments
    13.6 Pharscin Pharma
        13.6.1 Pharscin Pharma Company Information
        13.6.2 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
        13.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Pharscin Pharma Main Business Overview
        13.6.5 Pharscin Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of XIFAXAN
    Table 4. Major Players of Viberzi
    Table 5. Major Players of Lotronex
    Table 6. Major Players of Other
    Table 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2017-2022) & (K Units)
    Table 8. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2017-2022)
    Table 9. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2017-2022) & ($ million)
    Table 10. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2017-2022)
    Table 11. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Type (2017-2022) & (USD/Unit)
    Table 12. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2017-2022) & (K Units)
    Table 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2017-2022)
    Table 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Sales Channel (2017-2022)
    Table 15. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel (2017-2022)
    Table 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Sales Channel (2017-2022) & (USD/Unit)
    Table 17. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2020-2022) & (K Units)
    Table 18. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2020-2022)
    Table 19. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2020-2022) ($ Millions)
    Table 20. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2020-2022)
    Table 21. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Company (2020-2022) & (USD/Unit)
    Table 22. Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Producing Area Distribution and Sales Area
    Table 23. Players Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
    Table 24. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Geographic Region (2017-2022) & (K Units)
    Table 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Geographic Region (2017-2022)
    Table 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 30. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Geographic Region (2017-2022)
    Table 31. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country/Region (2017-2022) & (K Units)
    Table 32. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country/Region (2017-2022)
    Table 33. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country/Region (2017-2022) & ($ millions)
    Table 34. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country/Region (2017-2022)
    Table 35. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2017-2022)
    Table 37. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 38. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2017-2022)
    Table 41. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2017-2022) & (K Units)
    Table 42. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2017-2022)
    Table 43. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2017-2022) & (K Units)
    Table 44. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2017-2022)
    Table 45. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2017-2022) & ($ Millions)
    Table 46. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2017-2022)
    Table 47. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2017-2022) & (K Units)
    Table 48. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2017-2022)
    Table 49. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2017-2022) & (K Units)
    Table 50. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2017-2022)
    Table 51. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2022) & (K Units)
    Table 52. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2017-2022)
    Table 53. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 54. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2017-2022)
    Table 55. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2017-2022) & (K Units)
    Table 56. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2017-2022)
    Table 57. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2017-2022) & (K Units)
    Table 58. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2017-2022)
    Table 59. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2022) & (K Units)
    Table 60. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 62. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2017-2022) & (K Units)
    Table 64. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2017-2022)
    Table 65. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2017-2022) & (K Units)
    Table 66. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2017-2022)
    Table 67. Key Market Drivers & Growth Opportunities of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
    Table 68. Key Market Challenges & Risks of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
    Table 69. Key Industry Trends of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
    Table 70. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Material
    Table 71. Key Suppliers of Raw Materials
    Table 72. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
    Table 73. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customer List
    Table 74. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 75. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Forecast by Region
    Table 76. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 77. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 78. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 79. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 80. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 81. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 82. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 85. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 87. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 88. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 89. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 90. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Sales Channel (2023-2028) & (K Units)
    Table 91. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Sales Channel (2023-2028)
    Table 92. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Sales Channel (2023-2028) & ($ Millions)
    Table 93. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Sales Channel (2023-2028)
    Table 94. Bausch Health Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 95. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
    Table 96. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 97. Bausch Health Main Business
    Table 98. Bausch Health Latest Developments
    Table 99. Allergan Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 100. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
    Table 101. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 102. Allergan Main Business
    Table 103. Allergan Latest Developments
    Table 104. Sebela Pharmaceuticals Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 105. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
    Table 106. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 107. Sebela Pharmaceuticals Main Business
    Table 108. Sebela Pharmaceuticals Latest Developments
    Table 109. Astellas Pharmaceuticals Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 110. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
    Table 111. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 112. Astellas Pharmaceuticals Main Business
    Table 113. Astellas Pharmaceuticals Latest Developments
    Table 114. Amneal Pharms Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 115. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
    Table 116. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 117. Amneal Pharms Main Business
    Table 118. Amneal Pharms Latest Developments
    Table 119. Pharscin Pharma Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 120. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
    Table 121. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 122. Pharscin Pharma Main Business
    Table 123. Pharscin Pharma Latest Developments
List of Figures
    Figure 1. Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
    Figure 2. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of XIFAXAN
    Figure 10. Product Picture of Viberzi
    Figure 11. Product Picture of Lotronex
    Figure 12. Product Picture of Other
    Figure 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2021
    Figure 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2017-2022)
    Figure 15. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Hospitals Pharmacy
    Figure 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Hospitals Pharmacy (2017-2022) & (K Units)
    Figure 17. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Retail Pharmacy
    Figure 18. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Retail Pharmacy (2017-2022) & (K Units)
    Figure 19. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Other
    Figure 20. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Other (2017-2022) & (K Units)
    Figure 21. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2017-2022)
    Figure 22. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel in 2021
    Figure 23. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market by Company in 2021 ($ Million)
    Figure 24. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company in 2021
    Figure 25. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Geographic Region (2017-2022)
    Figure 26. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Geographic Region in 2021
    Figure 27. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2017-2022)
    Figure 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country/Region in 2021
    Figure 29. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2017-2022 (K Units)
    Figure 30. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2017-2022 ($ Millions)
    Figure 31. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2017-2022 (K Units)
    Figure 32. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2017-2022 ($ Millions)
    Figure 33. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2017-2022 (K Units)
    Figure 34. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2017-2022 ($ Millions)
    Figure 35. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2017-2022 (K Units)
    Figure 36. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2017-2022 ($ Millions)
    Figure 37. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2021
    Figure 38. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country in 2021
    Figure 39. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 43. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region in 2021
    Figure 44. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions in 2021
    Figure 45. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 47. South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 49. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2021
    Figure 52. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country in 2021
    Figure 53. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 54. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 55. UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2021
    Figure 59. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country in 2021
    Figure 60. Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 61. South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 64. GCC Country Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in 2021
    Figure 66. Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
    Figure 67. Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
    Figure 68. Channels of Distribution
    Figure 69. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Irritable Bowel Syndrome with Diarrhea Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Irritable Bowel Syndrome with Diarrhea Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Irritable Bowel Syndrome with Diarrhea Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Global Floor Market

As the global economy mends, the 2021 growth of Floor will have significant change from previous  ... Read More